Very early researchLooking for participantsNCT06565026What this trial is testingCS-206 in Patients With Sickle Cell DiseaseWho this might be right forSickle Cell Disease CorrectSequence Therapeutics Co., Ltd 5
Not applicableUnknownNCT04755478What this trial is testingLUS to Assess Lung Injury After Lung LobectomyWho this might be right forLung NeoplasmAdult ALLLung Injury+6 more Hospital General Universitario de Valencia 30
Not applicableStudy completedNCT00913042What this trial is testingAssessment of New Blood Culture Methods on the Microbiological Documentation of Febrile NeutropeniaWho this might be right forFebrileNeutropeniaPost-chemotherapy Assistance Publique - Hôpitaux de Paris 120
Post-approval studies (Phase 4)Active Not RecruitingNCT05144243What this trial is testingStudy to Assess Adverse Events and Change in Disease State of Oral Venetoclax in Combination With Subcutaneous (SC) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy in ChinaWho this might be right forAcute Myeloid Leukemia (AML) AbbVie 44
Not applicableLooking for participantsNCT03312686What this trial is testingChanges in Esophageal Distensibility With Proton Pump Inhibitors in Patients With Esophageal Eosinophilia: A Pilot StudyWho this might be right forEosinophilic Esophagitis Indiana University 10
Early research (Phase 1)Active Not RecruitingNCT05286229What this trial is testingAssess Adverse Events and Change in Disease State of Intravenously (IV) Infused Etentamig (ABBV-383) of Adult Participants With Relapsed or Refractory Multiple Myeloma in JapanWho this might be right forRelapsed/Refractory Multiple Myeloma AbbVie 8
Early research (Phase 1)UnknownNCT03114670What this trial is testingDonor-derived Anti-CD123-CART Cells for Recurred AML After Allo-HSCTWho this might be right forAdult Acute Myeloid Leukemia Affiliated Hospital to Academy of Military Medical Sciences 20
Not applicableStudy completedNCT04826523What this trial is testingStudy of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants Above 19 Years of Age With Acute Myeloid Leukemia (AML)Who this might be right forAcute Myeloid Leukemia (AML) AbbVie 150
Early research (Phase 1)Ended earlyNCT04895410What this trial is testingStudy to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Lemzoparlimab With or Without Oral/IV Dexamethasone and in Combination With Oral/IV/Subcutaneous Anti-Myeloma Regimens in Adult Participants With Multiple MyelomaWho this might be right forMultiple Myeloma AbbVie 8
Not applicableStudy completedNCT03217721What this trial is testingAntibiotics Management of Septic Neutropenic Patients in the Intensive Care UnitWho this might be right forNeutropenia, Febrile University Hospital, Brest 130
Testing effectiveness (Phase 2)Study completedNCT01716793What this trial is testingRisk-adapted Therapy for Adult Acute Myeloid Leukemia.Who this might be right forLeukemia, Myelocytic, Acute Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias 354
Not applicableWithdrawnNCT01769911What this trial is testingGenetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAIDS-related Diffuse Large Cell LymphomaAIDS-related Diffuse Mixed Cell Lymphoma+42 more Fred Hutchinson Cancer Center
Not applicableStudy completedNCT01681914What this trial is testingAssessment of the Effectiveness of New Clinical Guidelines for Differential Diagnosis and Management of Common HIV/AIDS-related Conditions in MozambiqueWho this might be right forAnemiaFeverHIV Positive Vanderbilt University 492
Testing effectiveness (Phase 2)UnknownNCT00247039What this trial is testingGarlic in Patients With Febrile NeutropeniaWho this might be right forChemotherapyNeutropenia Hadassah Medical Organization 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439357What this trial is testingTesting Trametinib as a Potential Targeted Treatment in Cancers With GNAQ or GNA11 Genetic Changes (MATCH-Subprotocol S2)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more National Cancer Institute (NCI) 4
Not applicableLooking for participantsNCT05793801What this trial is testingStudy of the Impact of Frequency of Changing PICCline Dressings in Patients With Acute LeukemiaWho this might be right forLeukemia Centre Hospitalier Universitaire de Nīmes 60
Not applicableLooking for participantsNCT07411079What this trial is testingEx Vivo Reproduction of Minimally Invasive Surgery With Hematoma Lysis Using Modified Tissue Plasminogen Activator for Intracerebral HemorrhageWho this might be right forIntracerebral HemorrhageHemorrhagic Risk ConditionsBleeding Disorders University Hospital, Lille 1,126
Early research (Phase 1)Looking for participantsNCT06835140What this trial is testingCD123-CD16-NK Cells Immunotherapy for AMLWho this might be right forAML (Acute Myelogenous Leukemia)NK CellCD123+ Acute Myeloid Leukemia Chunji Gao 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439279What this trial is testingTesting Trametinib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol R)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more National Cancer Institute (NCI) 35
Large-scale testing (Phase 3)Ended earlyNCT01434511What this trial is testingStudy of Modified Recombinant Factor VIII (OBI-1) in Subjects With Congenital Hemophilia AWho this might be right forHemophilia A Baxalta now part of Shire 1